Moreover, the inhibition of p90 ribosomal S6 kinase (RSK) has demonstrated potential in suppressing protein synthesis and tumor proliferation in melanoma cells that have developed dual resistance to BRAF and MEK inhibitors. The gene discussed is BRAF; the disease is neoplasm.